Cargando…
Targeting Super-Enhancers as a Therapeutic Strategy for Cancer Treatment
Super-enhancers (SEs) refer to large clusters of enhancers that drive gene expressions. Recent data has provided novel insights in elucidating the roles of SEs in many diseases, including cancer. Many mechanisms involved in tumorigenesis and progression, ranging from internal gene mutation and rearr...
Autores principales: | He, Yi, Long, Wenyong, Liu, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499164/ https://www.ncbi.nlm.nih.gov/pubmed/31105558 http://dx.doi.org/10.3389/fphar.2019.00361 |
Ejemplares similares
-
Targeting Tumor-Associated Antigen: A Promising CAR-T Therapeutic Strategy for Glioblastoma Treatment
por: Zhu, Guidong, et al.
Publicado: (2021) -
Identification of super-enhancer-driven peptidyl arginine deiminases as potential biomarkers and therapeutic targets for osimertinib-resistant non-small cell lung cancer
por: Li, Hang, et al.
Publicado: (2022) -
Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
por: Tang, Zhen-Chu, et al.
Publicado: (2023) -
Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells
por: Jagust, Petra, et al.
Publicado: (2019) -
Corrigendum: Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
por: Tang, Zhen-Chu, et al.
Publicado: (2023)